The Global Failure Analysis Equipment Market, By equipment (Scanning electron microscope (SEM), Transmission electron microscope (TEM), Focused Ion Beam system (FIB), and Dual - Beam (FIB/SEM) systems), By technology (Focused ion beam (FIB), Broad ion milling (BIM), Secondary ion mass spectroscopy (SIMS), Energy dispersive X-ray spectroscopy (EDX), Reactive ion etching (RIE), and Chemical mechanical planarization (CMP)), By end-use (Semiconductors manufacturing, Fiber optics, Bio-medical and life sciences, Metallurgy, Nanotechnology and nanomaterials, and Polymers), and by Region (North America, Latin America, Europe, APAC, RoW) - Global Forecast to 2027, is expected to be valued at US$ 13.53 billion by 2027, exhibiting a CAGR of 8.9% during the forecast period (2020-2027), as highlighted in a report published by Coherent Market Insights.
Failure analysis is the approach taken to determine how and why equipment or a component not working in the desired manner. The objective of future analysis equipment is to understand the root cause of the failure, in order to prevent similar incidences in the near future. Failure analysis equipment finds applications in a number of end-use segments namely semiconductors manufacturing, fiber optics, bio-medical and life sciences, polymers, metallurgy and nanotechnology, and nanomaterials.
The global failure analysis equipment market is estimated to account for US$ 13.53 Bn in terms of value by the end of 2027.
Growth of medical technologies in Asia Pacific is expected to boost the global failure analysis equipment market growth over the forecast period
Hospitals, clinics, academic medical centers, and laboratories provide sophisticated, technologically advanced care, and serve as a platform for biomedical innovation. The term medical technology encompasses a wide array of healthcare products (equipment, devices as well as supplies/ consumables) that are intended by manufacturers to be used specifically for diagnostic and therapeutic purposes. It includes any instrument, appliance, apparatus, implant, in vitro reagent, software, material or another article, which is used alone or in combination. Medical technology clearly stands out as the field where the most number of patents were registered, as per the European Patent Office (EPO). Therefore, these factors are expected to boost growth of the global failure analysis equipment market during the forecast period.
Rising technological advancements can present major growth opportunities
Key companies in the market are focused on research and development activities, in order to innovate new technologies and expand the market presence. For instance, in August 2013, Carl Zeiss SMT GmbH introduced an X-ray microscopy (XRM) solution that increases throughput for three-dimensional imaging at the nanoscale by up to ten times. The ZEISS Xradia 810 Ultra revolutionized the X-ray imaging model in scientific and industrial research labs worldwide. Key players in the market can capitalize on such opportunities by providing novel products and gain a competitive advantage in the market.
High capital investment is expected to hinder the global failure analysis equipment market growth over the forecast period
Equipment used in failure analysis requires a significant initial investment. Comparatively, optical microscopes cost much less than electron microscopes, but the latter offers superior features and applications. General Low power to high power optical microscope costs around USD 10,000 to USD 50,000, which is ten times lesser than the cost of electron microscopes. With increase in medical applications and research and education areas being given more importance in cost-sensitive regions such as Asia Pacific where the per capita income is much lower than countries such as North America, the adoption rate of failure analysis equipment needs to be encouraged. Hence, these factors are expected to hinder the market growth over the forecast period.
Among regions, North America is expected to witness significant growth in the global failure analysis equipment market during the forecast period. This is owing to increasing research and development activities and growing commercialization of nanotechnology-based products in the U.S. Furthermore, proactive initiatives by various organizations, institutions, and research laboratories in Canada is expected to boost the regional market growth.
Europe is expected to register lucrative growth rate in the global failure analysis equipment market over the forecast period. This is owing to growing biotechnology industry in the region. Furthermore, rising funding for research and development in microscopy and growth of the nanotechnology sector is expected to accelerate growth of the regional market during the forecast period.
Global Failure Analysis Equipment Market - Impact of Coronavirus (Covid-19) Pandemic
According to Coherent Market Insights’ analysis, the impact of coronavirus (COVID-19) pandemic on the failure analysis equipment is moderate. Due to lockdown in countries such as China and India, supply chain is mainly disturbed. Furthermore, many key players in the market remains operational with limited people working on the shop floor and remaining people are working from home, which lowered the production capacity of the factory. For instance, in April 2020, Coherent, Inc., a US based electronics component manufacturing company implemented COVID 19 regulations such as social distancing norm, for employees working in the factory floor. Further company provided work from facility to the remaining employees to reduce the spread of COVID 19 pandemic
Key companies operating in the global failure analysis equipment market are Carl Zeiss SMT GmbH, JEOL, Ltd., FEI Company, Veeco Instruments, Hitachi High-Technologies Europe GmbH, TESCAN OSRAY HOLDING, A&D Company, Ltd., Oxford Instruments, Bruker, and Eurofins Scientific.